Roche Dismisses Promega Lawsuit As Baseless

Law360, New York (November 14, 2003, 12:00 AM EST) -- Swiss pharmaceutical group Roche on Friday dismissed a lawsuit filed by U.S. rival Promega as a groundless legal tactic in a decade-long patent dispute between the pair, Agence France Press reported.

On Thursday, Promega said it had sued Hoffman-La Roche for overcharging the US government for products used for research and healthcare. Promega alleged that the overcharges included royalty payments to use a research enzyme called Taq based on a Roche patent, the subject of a legal dispute between the two companies.

Roche sued Promega in...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.